×
A Crew of Worms on the ISS Aims to Help Scientists Unlock the Secrets of Space Travel
                Shortly after four astronauts returned from their trip around the Moon, a crew of tiny space travelers were already on the move. Scientists sent microscopic worms to the International Space Station (ISS) as part of the same broader effort to extend human presence deeper into space. The space-faring worms arrived at the space station on Monday aboard Northrop Grumman’s Cygnus XL spacecraft. The uncrewed spacecraft delivered about 11,000 pounds (4,990 kilograms) of science equipment and supplies to the ISS, including a miniature space laboratory with the wriggly inhabitants inside.

 The scientists behind the experiment are hoping these small creatures will help better inform them on human health during long duration space travel. Space worms The experiment, led by the University of Exeter in England, is designed to study how living organisms respond to the harsh space environment. “It might sound surprising, but these tiny worms could play a big role in the future of human spaceflight,” U.K. Space Minister Liz Lloyd said in a statement. The worms are called C. elegans nematode worms, a tiny roundworm that measures around 1 millimeter in length. Because of its transparent body, researchers can watch its cells develop under a microscope. The roundworm is also fast-growing and genetically tractable, making it an ideal candidate for biological research.

 The worms are placed inside a miniature lab called the Petri Pod. The self-contained experiment is housed in a unit that measures approximately 4 x 11 inches (10 x 30 centimeters) and weighs around 6 pounds (3 kilograms). The Petri Pod provides a miniaturized life support system. Credit: University of Exeter The unit has 12 chambers, four of which can be actively imaged using fluorescent and white light. Each chamber provides a miniaturized life support environment for the worms, maintaining temperature, pressure and a trapped volume of air for them to breathe when exposed to the vacuum of space. They will also receive a supply of food through an agar carrier.

 Miniature mission The worms will spend some time inside the space station before being mounted on the outside of the ISS. From there, the small creatures will spend around 15 weeks inside their miniaturized environment while being exposed to zero-gravity and radiation of outer space. Throughout that time, the researchers will monitor the worms’ health, using miniaturized cameras to capture stills and time-lapse videos. The experiment will collect data on temperature, pressure, and accumulated dose of radiation experienced by the worms, and send the data back to Earth.

 “NASA’s Artemis programme marks a new era of human exploration, with astronauts set to live and work on the Moon for extended periods for the first time. To do that safely, we need to understand how the body responds to the extreme conditions of deep space,” Tim Etheridge, a researcher at the University of Exeter Medical School, said in a statement. “By studying how these worms survive and adapt in space, we can begin to identify the biological mechanisms that will ultimately help protect astronauts during long-duration missions – and bring us one step closer to humans living on the Moon.”      #Crew #Worms #ISS #Aims #Scientists #Unlock #Secrets #Space #Travelinternational space station,Worms

A Crew of Worms on the ISS Aims to Help Scientists Unlock the Secrets of Space Travel

Shortly after four astronauts returned from their trip around the Moon, a crew of tiny space travelers were already on the move. Scientists sent microscopic worms to the International Space Station (ISS) as part of the same broader effort to extend human presence deeper into space.

The space-faring worms arrived at the space station on Monday aboard Northrop Grumman’s Cygnus XL spacecraft. The uncrewed spacecraft delivered about 11,000 pounds (4,990 kilograms) of science equipment and supplies to the ISS, including a miniature space laboratory with the wriggly inhabitants inside.

The scientists behind the experiment are hoping these small creatures will help better inform them on human health during long duration space travel.

Space worms

The experiment, led by the University of Exeter in England, is designed to study how living organisms respond to the harsh space environment. “It might sound surprising, but these tiny worms could play a big role in the future of human spaceflight,” U.K. Space Minister Liz Lloyd said in a statement.

The worms are called C. elegans nematode worms, a tiny roundworm that measures around 1 millimeter in length. Because of its transparent body, researchers can watch its cells develop under a microscope. The roundworm is also fast-growing and genetically tractable, making it an ideal candidate for biological research.

The worms are placed inside a miniature lab called the Petri Pod. The self-contained experiment is housed in a unit that measures approximately 4 x 11 inches (10 x 30 centimeters) and weighs around 6 pounds (3 kilograms).

A Crew of Worms on the ISS Aims to Help Scientists Unlock the Secrets of Space Travel
                Shortly after four astronauts returned from their trip around the Moon, a crew of tiny space travelers were already on the move. Scientists sent microscopic worms to the International Space Station (ISS) as part of the same broader effort to extend human presence deeper into space. The space-faring worms arrived at the space station on Monday aboard Northrop Grumman’s Cygnus XL spacecraft. The uncrewed spacecraft delivered about 11,000 pounds (4,990 kilograms) of science equipment and supplies to the ISS, including a miniature space laboratory with the wriggly inhabitants inside.

 The scientists behind the experiment are hoping these small creatures will help better inform them on human health during long duration space travel. Space worms The experiment, led by the University of Exeter in England, is designed to study how living organisms respond to the harsh space environment. “It might sound surprising, but these tiny worms could play a big role in the future of human spaceflight,” U.K. Space Minister Liz Lloyd said in a statement. The worms are called C. elegans nematode worms, a tiny roundworm that measures around 1 millimeter in length. Because of its transparent body, researchers can watch its cells develop under a microscope. The roundworm is also fast-growing and genetically tractable, making it an ideal candidate for biological research.

 The worms are placed inside a miniature lab called the Petri Pod. The self-contained experiment is housed in a unit that measures approximately 4 x 11 inches (10 x 30 centimeters) and weighs around 6 pounds (3 kilograms). The Petri Pod provides a miniaturized life support system. Credit: University of Exeter The unit has 12 chambers, four of which can be actively imaged using fluorescent and white light. Each chamber provides a miniaturized life support environment for the worms, maintaining temperature, pressure and a trapped volume of air for them to breathe when exposed to the vacuum of space. They will also receive a supply of food through an agar carrier.

 Miniature mission The worms will spend some time inside the space station before being mounted on the outside of the ISS. From there, the small creatures will spend around 15 weeks inside their miniaturized environment while being exposed to zero-gravity and radiation of outer space. Throughout that time, the researchers will monitor the worms’ health, using miniaturized cameras to capture stills and time-lapse videos. The experiment will collect data on temperature, pressure, and accumulated dose of radiation experienced by the worms, and send the data back to Earth.

 “NASA’s Artemis programme marks a new era of human exploration, with astronauts set to live and work on the Moon for extended periods for the first time. To do that safely, we need to understand how the body responds to the extreme conditions of deep space,” Tim Etheridge, a researcher at the University of Exeter Medical School, said in a statement. “By studying how these worms survive and adapt in space, we can begin to identify the biological mechanisms that will ultimately help protect astronauts during long-duration missions – and bring us one step closer to humans living on the Moon.”      #Crew #Worms #ISS #Aims #Scientists #Unlock #Secrets #Space #Travelinternational space station,Worms
The Petri Pod provides a miniaturized life support system. Credit: University of Exeter

The unit has 12 chambers, four of which can be actively imaged using fluorescent and white light. Each chamber provides a miniaturized life support environment for the worms, maintaining temperature, pressure and a trapped volume of air for them to breathe when exposed to the vacuum of space. They will also receive a supply of food through an agar carrier.

Miniature mission

The worms will spend some time inside the space station before being mounted on the outside of the ISS. From there, the small creatures will spend around 15 weeks inside their miniaturized environment while being exposed to zero-gravity and radiation of outer space.

Throughout that time, the researchers will monitor the worms’ health, using miniaturized cameras to capture stills and time-lapse videos. The experiment will collect data on temperature, pressure, and accumulated dose of radiation experienced by the worms, and send the data back to Earth.

“NASA’s Artemis programme marks a new era of human exploration, with astronauts set to live and work on the Moon for extended periods for the first time. To do that safely, we need to understand how the body responds to the extreme conditions of deep space,” Tim Etheridge, a researcher at the University of Exeter Medical School, said in a statement. “By studying how these worms survive and adapt in space, we can begin to identify the biological mechanisms that will ultimately help protect astronauts during long-duration missions – and bring us one step closer to humans living on the Moon.”

#Crew #Worms #ISS #Aims #Scientists #Unlock #Secrets #Space #Travelinternational space station,Worms

Shortly after four astronauts returned from their trip around the Moon, a crew of tiny space travelers were already on the move. Scientists sent microscopic worms to the International Space Station (ISS) as part of the same broader effort to extend human presence deeper into space.

The space-faring worms arrived at the space station on Monday aboard Northrop Grumman’s Cygnus XL spacecraft. The uncrewed spacecraft delivered about 11,000 pounds (4,990 kilograms) of science equipment and supplies to the ISS, including a miniature space laboratory with the wriggly inhabitants inside.

The scientists behind the experiment are hoping these small creatures will help better inform them on human health during long duration space travel.

Space worms

The experiment, led by the University of Exeter in England, is designed to study how living organisms respond to the harsh space environment. “It might sound surprising, but these tiny worms could play a big role in the future of human spaceflight,” U.K. Space Minister Liz Lloyd said in a statement.

The worms are called C. elegans nematode worms, a tiny roundworm that measures around 1 millimeter in length. Because of its transparent body, researchers can watch its cells develop under a microscope. The roundworm is also fast-growing and genetically tractable, making it an ideal candidate for biological research.

The worms are placed inside a miniature lab called the Petri Pod. The self-contained experiment is housed in a unit that measures approximately 4 x 11 inches (10 x 30 centimeters) and weighs around 6 pounds (3 kilograms).

The Petri Pod provides a miniaturized life support system. Credit: University of Exeter

The unit has 12 chambers, four of which can be actively imaged using fluorescent and white light. Each chamber provides a miniaturized life support environment for the worms, maintaining temperature, pressure and a trapped volume of air for them to breathe when exposed to the vacuum of space. They will also receive a supply of food through an agar carrier.

Miniature mission

The worms will spend some time inside the space station before being mounted on the outside of the ISS. From there, the small creatures will spend around 15 weeks inside their miniaturized environment while being exposed to zero-gravity and radiation of outer space.

Throughout that time, the researchers will monitor the worms’ health, using miniaturized cameras to capture stills and time-lapse videos. The experiment will collect data on temperature, pressure, and accumulated dose of radiation experienced by the worms, and send the data back to Earth.

“NASA’s Artemis programme marks a new era of human exploration, with astronauts set to live and work on the Moon for extended periods for the first time. To do that safely, we need to understand how the body responds to the extreme conditions of deep space,” Tim Etheridge, a researcher at the University of Exeter Medical School, said in a statement. “By studying how these worms survive and adapt in space, we can begin to identify the biological mechanisms that will ultimately help protect astronauts during long-duration missions – and bring us one step closer to humans living on the Moon.”

Source link
#Crew #Worms #ISS #Aims #Scientists #Unlock #Secrets #Space #Travel

Previous post

15 Sequels That Totally Ignored What Made the Original Work | Den of Geek

Next post

RCB vs LSG IPL 2026: Virat Kohli to play as Impact Sub against Lucknow Super Giants <div id="content-body-70865531" itemprop="articleBody"><p>For the first time in his IPL career, Virat Kohli will play as an impact sub in Royal Challengers Bengaluru’s match against Lucknow Super Giants at the M Chinnaswamy Stadium on Wednesday night.</p><p>Kohli, one of the best fielders in the RCB outfit, will not take the field in the first innings after RCB captain Rajat Patidar won the toss and chose to bowl first.</p><p>The 37-year-old did not field in RCB’s last match against Mumbai Indians as well, after facing an issue with his left ankle. It is understood that the decision to play Kohli as an impact sub was taken as a precautionary measure.</p><p><b>FOLLOW THE IPL 2026 LIVE:</b><b><a href="https://sportstar.thehindu.com/cricket/ipl/rcb-vs-lsg-live-score-royal-challengers-bengaluru-lucknow-super-giants-ipl-2026-live-updates-april-15/article70862586.ece" target="_blank" rel="nofollow">RCB vs LSG Live Score, IPL 2026: Royal Challengers Bengaluru wins the toss and opts to field; Hazlewood returns for Duffy</a></b></p><p>Kohli is expected to open the batting in the second innings as Rajat Patidar confirmed only one change in the starting lineup at the toss- Josh Hazlewood for Jacob Duffy.</p><p class="publish-time" id="end-of-article">Published on Apr 15, 2026</p></div> #RCB #LSG #IPL #Virat #Kohli #play #Impact #Lucknow #Super #Giants

ASUS Chromebook CM32 Detachable Leads the Lineup
ASUS Expands Chromebook Lineup in India With New CM14, CM15, and CM32 Models
	
Chromebooks aren’t exactly the most exciting laptops on the market, but they continue to be a popular option for students and anyone who primarily works in the cloud. Looking to capitalize on that demand, ASUS has launched three new Chromebooks in India, including a detachable 2-in-1 model that doubles as a tablet.



The new lineup consists of the ASUS Chromebook CM32 Detachable, Chromebook CM14, and Chromebook CM15. All three devices run ChromeOS and come with Google’s latest AI-powered features, along with cloud-first productivity tools aimed at students, educators, and young professionals. ASUS is also bundling three months of Google AI Pro with the devices, giving buyers access to Google’s AI tools and 5TB of cloud storage.



ASUS Chromebook CM32 Detachable Leads the Lineup







Leading the lineup is the ASUS Chromebook CM32, a 2-in-1 device designed for users who want the flexibility of both a tablet and a laptop. The device features a 2.5K touchscreen display, a detachable keyboard, a magnetic kickstand, and support for the ASUS Pen. This makes it suitable for everything from note-taking and studying to media consumption and light gaming.



ASUS has also focused on portability and durability. Despite its lightweight design, the Chromebook comes with military-grade durability certifications and Corning Gorilla Glass protection, making it better equipped to handle everyday wear and tear.



Chromebook CM14 and CM15 Focus on Battery Life







If you prefer a traditional laptop design, ASUS is also offering the Chromebook CM14 and Chromebook CM15. The two laptops feature 14-inch and 15-inch displays, respectively, and are powered by the MediaTek Kompanio 540 processor. While these aren’t performance-focused machines, they should be more than capable of handling web browsing, document editing, online classes, and other everyday workloads.



One of the standout features is battery life. ASUS claims both laptops can deliver up to 20 hours of usage on a single charge, which should easily get most users through a full day of work or study. The laptops also include a 180-degree hinge, allowing users to lay the display flat for easier collaboration during meetings, presentations, or classroom sessions.



Price and Availability



The new ASUS Chromebook lineup is now available through Amazon and the ASUS eShop. Pricing starts at ₹26,990 for the Chromebook CM14, while the larger Chromebook CM15 starts at ₹28,990. The more premium Chromebook CM32 Detachable is priced at ₹37,990. ASUS is also offering No Cost EMI and ASUS Easy Pay financing options. Monthly installments start at ₹5,165 for the CM14, ₹5,665 for the CM15, and ₹6,332 for the CM32 Detachable.





#ASUS #Expands #Chromebook #Lineup #India #CM14 #CM15 #CM32 #ModelsAsus

Leading the lineup is the ASUS Chromebook CM32, a 2-in-1 device designed for users who want the flexibility of both a tablet and a laptop. The device features a 2.5K touchscreen display, a detachable keyboard, a magnetic kickstand, and support for the ASUS Pen. This makes it suitable for everything from note-taking and studying to media consumption and light gaming.

ASUS has also focused on portability and durability. Despite its lightweight design, the Chromebook comes with military-grade durability certifications and Corning Gorilla Glass protection, making it better equipped to handle everyday wear and tear.

Chromebook CM14 and CM15 Focus on Battery Life

If you prefer a traditional laptop design, ASUS is also offering the Chromebook CM14 and Chromebook CM15. The two laptops feature 14-inch and 15-inch displays, respectively, and are powered by the MediaTek Kompanio 540 processor. While these aren’t performance-focused machines, they should be more than capable of handling web browsing, document editing, online classes, and other everyday workloads.

One of the standout features is battery life. ASUS claims both laptops can deliver up to 20 hours of usage on a single charge, which should easily get most users through a full day of work or study. The laptops also include a 180-degree hinge, allowing users to lay the display flat for easier collaboration during meetings, presentations, or classroom sessions.

Price and Availability

The new ASUS Chromebook lineup is now available through Amazon and the ASUS eShop. Pricing starts at ₹26,990 for the Chromebook CM14, while the larger Chromebook CM15 starts at ₹28,990. The more premium Chromebook CM32 Detachable is priced at ₹37,990. ASUS is also offering No Cost EMI and ASUS Easy Pay financing options. Monthly installments start at ₹5,165 for the CM14, ₹5,665 for the CM15, and ₹6,332 for the CM32 Detachable.

#ASUS #Expands #Chromebook #Lineup #India #CM14 #CM15 #CM32 #ModelsAsus">ASUS Expands Chromebook Lineup in India With New CM14, CM15, and CM32 Models
	
Chromebooks aren’t exactly the most exciting laptops on the market, but they continue to be a popular option for students and anyone who primarily works in the cloud. Looking to capitalize on that demand, ASUS has launched three new Chromebooks in India, including a detachable 2-in-1 model that doubles as a tablet.



The new lineup consists of the ASUS Chromebook CM32 Detachable, Chromebook CM14, and Chromebook CM15. All three devices run ChromeOS and come with Google’s latest AI-powered features, along with cloud-first productivity tools aimed at students, educators, and young professionals. ASUS is also bundling three months of Google AI Pro with the devices, giving buyers access to Google’s AI tools and 5TB of cloud storage.



ASUS Chromebook CM32 Detachable Leads the Lineup







Leading the lineup is the ASUS Chromebook CM32, a 2-in-1 device designed for users who want the flexibility of both a tablet and a laptop. The device features a 2.5K touchscreen display, a detachable keyboard, a magnetic kickstand, and support for the ASUS Pen. This makes it suitable for everything from note-taking and studying to media consumption and light gaming.



ASUS has also focused on portability and durability. Despite its lightweight design, the Chromebook comes with military-grade durability certifications and Corning Gorilla Glass protection, making it better equipped to handle everyday wear and tear.



Chromebook CM14 and CM15 Focus on Battery Life







If you prefer a traditional laptop design, ASUS is also offering the Chromebook CM14 and Chromebook CM15. The two laptops feature 14-inch and 15-inch displays, respectively, and are powered by the MediaTek Kompanio 540 processor. While these aren’t performance-focused machines, they should be more than capable of handling web browsing, document editing, online classes, and other everyday workloads.



One of the standout features is battery life. ASUS claims both laptops can deliver up to 20 hours of usage on a single charge, which should easily get most users through a full day of work or study. The laptops also include a 180-degree hinge, allowing users to lay the display flat for easier collaboration during meetings, presentations, or classroom sessions.



Price and Availability



The new ASUS Chromebook lineup is now available through Amazon and the ASUS eShop. Pricing starts at ₹26,990 for the Chromebook CM14, while the larger Chromebook CM15 starts at ₹28,990. The more premium Chromebook CM32 Detachable is priced at ₹37,990. ASUS is also offering No Cost EMI and ASUS Easy Pay financing options. Monthly installments start at ₹5,165 for the CM14, ₹5,665 for the CM15, and ₹6,332 for the CM32 Detachable.





#ASUS #Expands #Chromebook #Lineup #India #CM14 #CM15 #CM32 #ModelsAsus

ASUS Chromebook CM32, a 2-in-1 device designed for users who want the flexibility of both a tablet and a laptop. The device features a 2.5K touchscreen display, a detachable keyboard, a magnetic kickstand, and support for the ASUS Pen. This makes it suitable for everything from note-taking and studying to media consumption and light gaming.

ASUS has also focused on portability and durability. Despite its lightweight design, the Chromebook comes with military-grade durability certifications and Corning Gorilla Glass protection, making it better equipped to handle everyday wear and tear.

Chromebook CM14 and CM15 Focus on Battery Life

If you prefer a traditional laptop design, ASUS is also offering the Chromebook CM14 and Chromebook CM15. The two laptops feature 14-inch and 15-inch displays, respectively, and are powered by the MediaTek Kompanio 540 processor. While these aren’t performance-focused machines, they should be more than capable of handling web browsing, document editing, online classes, and other everyday workloads.

One of the standout features is battery life. ASUS claims both laptops can deliver up to 20 hours of usage on a single charge, which should easily get most users through a full day of work or study. The laptops also include a 180-degree hinge, allowing users to lay the display flat for easier collaboration during meetings, presentations, or classroom sessions.

Price and Availability

The new ASUS Chromebook lineup is now available through Amazon and the ASUS eShop. Pricing starts at ₹26,990 for the Chromebook CM14, while the larger Chromebook CM15 starts at ₹28,990. The more premium Chromebook CM32 Detachable is priced at ₹37,990. ASUS is also offering No Cost EMI and ASUS Easy Pay financing options. Monthly installments start at ₹5,165 for the CM14, ₹5,665 for the CM15, and ₹6,332 for the CM32 Detachable.

#ASUS #Expands #Chromebook #Lineup #India #CM14 #CM15 #CM32 #ModelsAsus">ASUS Expands Chromebook Lineup in India With New CM14, CM15, and CM32 Models

Chromebooks aren’t exactly the most exciting laptops on the market, but they continue to be a popular option for students and anyone who primarily works in the cloud. Looking to capitalize on that demand, ASUS has launched three new Chromebooks in India, including a detachable 2-in-1 model that doubles as a tablet.

The new lineup consists of the ASUS Chromebook CM32 Detachable, Chromebook CM14, and Chromebook CM15. All three devices run ChromeOS and come with Google’s latest AI-powered features, along with cloud-first productivity tools aimed at students, educators, and young professionals. ASUS is also bundling three months of Google AI Pro with the devices, giving buyers access to Google’s AI tools and 5TB of cloud storage.

ASUS Chromebook CM32 Detachable Leads the Lineup

ASUS Expands Chromebook Lineup in India With New CM14, CM15, and CM32 Models
	
Chromebooks aren’t exactly the most exciting laptops on the market, but they continue to be a popular option for students and anyone who primarily works in the cloud. Looking to capitalize on that demand, ASUS has launched three new Chromebooks in India, including a detachable 2-in-1 model that doubles as a tablet.



The new lineup consists of the ASUS Chromebook CM32 Detachable, Chromebook CM14, and Chromebook CM15. All three devices run ChromeOS and come with Google’s latest AI-powered features, along with cloud-first productivity tools aimed at students, educators, and young professionals. ASUS is also bundling three months of Google AI Pro with the devices, giving buyers access to Google’s AI tools and 5TB of cloud storage.



ASUS Chromebook CM32 Detachable Leads the Lineup







Leading the lineup is the ASUS Chromebook CM32, a 2-in-1 device designed for users who want the flexibility of both a tablet and a laptop. The device features a 2.5K touchscreen display, a detachable keyboard, a magnetic kickstand, and support for the ASUS Pen. This makes it suitable for everything from note-taking and studying to media consumption and light gaming.



ASUS has also focused on portability and durability. Despite its lightweight design, the Chromebook comes with military-grade durability certifications and Corning Gorilla Glass protection, making it better equipped to handle everyday wear and tear.



Chromebook CM14 and CM15 Focus on Battery Life







If you prefer a traditional laptop design, ASUS is also offering the Chromebook CM14 and Chromebook CM15. The two laptops feature 14-inch and 15-inch displays, respectively, and are powered by the MediaTek Kompanio 540 processor. While these aren’t performance-focused machines, they should be more than capable of handling web browsing, document editing, online classes, and other everyday workloads.



One of the standout features is battery life. ASUS claims both laptops can deliver up to 20 hours of usage on a single charge, which should easily get most users through a full day of work or study. The laptops also include a 180-degree hinge, allowing users to lay the display flat for easier collaboration during meetings, presentations, or classroom sessions.



Price and Availability



The new ASUS Chromebook lineup is now available through Amazon and the ASUS eShop. Pricing starts at ₹26,990 for the Chromebook CM14, while the larger Chromebook CM15 starts at ₹28,990. The more premium Chromebook CM32 Detachable is priced at ₹37,990. ASUS is also offering No Cost EMI and ASUS Easy Pay financing options. Monthly installments start at ₹5,165 for the CM14, ₹5,665 for the CM15, and ₹6,332 for the CM32 Detachable.





#ASUS #Expands #Chromebook #Lineup #India #CM14 #CM15 #CM32 #ModelsAsus

Leading the lineup is the ASUS Chromebook CM32, a 2-in-1 device designed for users who want the flexibility of both a tablet and a laptop. The device features a 2.5K touchscreen display, a detachable keyboard, a magnetic kickstand, and support for the ASUS Pen. This makes it suitable for everything from note-taking and studying to media consumption and light gaming.

ASUS has also focused on portability and durability. Despite its lightweight design, the Chromebook comes with military-grade durability certifications and Corning Gorilla Glass protection, making it better equipped to handle everyday wear and tear.

Chromebook CM14 and CM15 Focus on Battery Life

If you prefer a traditional laptop design, ASUS is also offering the Chromebook CM14 and Chromebook CM15. The two laptops feature 14-inch and 15-inch displays, respectively, and are powered by the MediaTek Kompanio 540 processor. While these aren’t performance-focused machines, they should be more than capable of handling web browsing, document editing, online classes, and other everyday workloads.

One of the standout features is battery life. ASUS claims both laptops can deliver up to 20 hours of usage on a single charge, which should easily get most users through a full day of work or study. The laptops also include a 180-degree hinge, allowing users to lay the display flat for easier collaboration during meetings, presentations, or classroom sessions.

Price and Availability

The new ASUS Chromebook lineup is now available through Amazon and the ASUS eShop. Pricing starts at ₹26,990 for the Chromebook CM14, while the larger Chromebook CM15 starts at ₹28,990. The more premium Chromebook CM32 Detachable is priced at ₹37,990. ASUS is also offering No Cost EMI and ASUS Easy Pay financing options. Monthly installments start at ₹5,165 for the CM14, ₹5,665 for the CM15, and ₹6,332 for the CM32 Detachable.

#ASUS #Expands #Chromebook #Lineup #India #CM14 #CM15 #CM32 #ModelsAsus

published late last week in the journal Nature Microbiology.

Good guy prions?

Prions are some of the strangest things around. They’re the misfolded form of a protein naturally found in the body. When a prion comes across its “normal” counterpart, it can somehow induce the latter to turn into a prion itself, almost like a zombie infection.

Classic prion disorders like mad cow disease and Creutzfeldt-Jakob disease are caused by the steady accumulation of one particular type of protein, aptly named the prion protein; these disorders are universally fatal. Some scientists have also argued that other neurodegenerative conditions, such as Alzheimer’s disease, are caused by other kinds of misfolded proteins that act in a similar way to prions.

According to the study researchers, there’s growing evidence that prions and prion-like proteins are more than just harbingers of death. Studies have found that the normal prion protein and the prion-like amyloid beta (one of the drivers of Alzheimer’s) can have antimicrobial activity, for instance. So the team decided to conduct a sweeping analysis looking for antimicrobial peptide fragments within these proteins.

The researchers had previously built an AI model intended to predict the antimicrobial activity of any given peptide fragment, named APEX 1.1. Then they let APEX scan through 19.3 million short peptide fragments found in 2,897 prion and prion-like proteins. They initially uncovered 1,179 candidates, which the team narrowed down to 75 that showed the most potential. Of these, 59 were able to inhibit the growth of at least one bacterial germ in the lab, including 42 that did so at low levels (important for dosing considerations).

Finally, the researchers tested two of the strongest candidates on the skin of mice infected with Acinetobacter baumannii, a common source of drug-resistant infections in people. The candidates appeared to be roughly as effective as polymyxin B, an existing antibiotic often used as a last resort drug for certain drug-resistant infections.

The researchers have coined these antibacterial fragments collected from prions as “prionins.”

The future of prionins

More research is obviously needed to verify whether the team’s prionins can actually work as hoped—and safely—in people. The researchers also note their findings don’t settle the open question as to whether prions or prion-like proteins naturally tackle bacterial infections in our body.

At the same time, they do argue their work provides a strong proof of concept that prionins identified through AI can be viable antibiotic candidates for further testing.

“For a long time, drug discovery has been limited not only by what we can test, but by where we choose to look,” said senior study author César de la Fuente, director of the Machine Biology Group at the University of Pennsylvania Perelman School of Medicine, in a statement from the university. “AI is changing that. It gives us a way to search the hidden layers of biology and ask whether molecules associated with one story—in this case, disease—may also carry another story with therapeutic potential.”

With any luck, the proteins known for causing the scariest diseases around could someday turn into our antibacterial allies.

#Deadly #Proteins #Mad #Cow #Disease #Fight #Superbugsantibiotic resistance,experimental drugs,prions">Deadly Proteins Behind Mad Cow Disease Might Help Us Fight Superbugs
                The next frontier of antibiotics might come from an unexpected place. Recent research identifies potential antibiotic candidates from inside prions—proteins capable of causing some of the deadliest brain infections ever known, such as mad cow disease.

 Scientists at the University of Pennsylvania used artificial intelligence to rapidly search hundreds of prions and prion-like proteins for peptides with antibacterial activity. They found several dozen promising candidates, two of which have already shown results treating bacterial infections in mice. The team’s findings establish “prion-related proteins as a productive source space for antibiotic discovery,” the scientists wrote in their paper, published late last week in the journal Nature Microbiology.

 Good guy prions? Prions are some of the strangest things around. They’re the misfolded form of a protein naturally found in the body. When a prion comes across its “normal” counterpart, it can somehow induce the latter to turn into a prion itself, almost like a zombie infection.

 Classic prion disorders like mad cow disease and Creutzfeldt-Jakob disease are caused by the steady accumulation of one particular type of protein, aptly named the prion protein; these disorders are universally fatal. Some scientists have also argued that other neurodegenerative conditions, such as Alzheimer’s disease, are caused by other kinds of misfolded proteins that act in a similar way to prions.   According to the study researchers, there’s growing evidence that prions and prion-like proteins are more than just harbingers of death. Studies have found that the normal prion protein and the prion-like amyloid beta (one of the drivers of Alzheimer’s) can have antimicrobial activity, for instance. So the team decided to conduct a sweeping analysis looking for antimicrobial peptide fragments within these proteins.

 The researchers had previously built an AI model intended to predict the antimicrobial activity of any given peptide fragment, named APEX 1.1. Then they let APEX scan through 19.3 million short peptide fragments found in 2,897 prion and prion-like proteins. They initially uncovered 1,179 candidates, which the team narrowed down to 75 that showed the most potential. Of these, 59 were able to inhibit the growth of at least one bacterial germ in the lab, including 42 that did so at low levels (important for dosing considerations). Finally, the researchers tested two of the strongest candidates on the skin of mice infected with Acinetobacter baumannii, a common source of drug-resistant infections in people. The candidates appeared to be roughly as effective as polymyxin B, an existing antibiotic often used as a last resort drug for certain drug-resistant infections. The researchers have coined these antibacterial fragments collected from prions as “prionins.”

 The future of prionins More research is obviously needed to verify whether the team’s prionins can actually work as hoped—and safely—in people. The researchers also note their findings don’t settle the open question as to whether prions or prion-like proteins naturally tackle bacterial infections in our body. At the same time, they do argue their work provides a strong proof of concept that prionins identified through AI can be viable antibiotic candidates for further testing. “For a long time, drug discovery has been limited not only by what we can test, but by where we choose to look,” said senior study author César de la Fuente, director of the Machine Biology Group at the University of Pennsylvania Perelman School of Medicine, in a statement from the university. “AI is changing that. It gives us a way to search the hidden layers of biology and ask whether molecules associated with one story—in this case, disease—may also carry another story with therapeutic potential.”

 With any luck, the proteins known for causing the scariest diseases around could someday turn into our antibacterial allies.      #Deadly #Proteins #Mad #Cow #Disease #Fight #Superbugsantibiotic resistance,experimental drugs,prions

published late last week in the journal Nature Microbiology.

Good guy prions?

Prions are some of the strangest things around. They’re the misfolded form of a protein naturally found in the body. When a prion comes across its “normal” counterpart, it can somehow induce the latter to turn into a prion itself, almost like a zombie infection.

Classic prion disorders like mad cow disease and Creutzfeldt-Jakob disease are caused by the steady accumulation of one particular type of protein, aptly named the prion protein; these disorders are universally fatal. Some scientists have also argued that other neurodegenerative conditions, such as Alzheimer’s disease, are caused by other kinds of misfolded proteins that act in a similar way to prions.

According to the study researchers, there’s growing evidence that prions and prion-like proteins are more than just harbingers of death. Studies have found that the normal prion protein and the prion-like amyloid beta (one of the drivers of Alzheimer’s) can have antimicrobial activity, for instance. So the team decided to conduct a sweeping analysis looking for antimicrobial peptide fragments within these proteins.

The researchers had previously built an AI model intended to predict the antimicrobial activity of any given peptide fragment, named APEX 1.1. Then they let APEX scan through 19.3 million short peptide fragments found in 2,897 prion and prion-like proteins. They initially uncovered 1,179 candidates, which the team narrowed down to 75 that showed the most potential. Of these, 59 were able to inhibit the growth of at least one bacterial germ in the lab, including 42 that did so at low levels (important for dosing considerations).

Finally, the researchers tested two of the strongest candidates on the skin of mice infected with Acinetobacter baumannii, a common source of drug-resistant infections in people. The candidates appeared to be roughly as effective as polymyxin B, an existing antibiotic often used as a last resort drug for certain drug-resistant infections.

The researchers have coined these antibacterial fragments collected from prions as “prionins.”

The future of prionins

More research is obviously needed to verify whether the team’s prionins can actually work as hoped—and safely—in people. The researchers also note their findings don’t settle the open question as to whether prions or prion-like proteins naturally tackle bacterial infections in our body.

At the same time, they do argue their work provides a strong proof of concept that prionins identified through AI can be viable antibiotic candidates for further testing.

“For a long time, drug discovery has been limited not only by what we can test, but by where we choose to look,” said senior study author César de la Fuente, director of the Machine Biology Group at the University of Pennsylvania Perelman School of Medicine, in a statement from the university. “AI is changing that. It gives us a way to search the hidden layers of biology and ask whether molecules associated with one story—in this case, disease—may also carry another story with therapeutic potential.”

With any luck, the proteins known for causing the scariest diseases around could someday turn into our antibacterial allies.

#Deadly #Proteins #Mad #Cow #Disease #Fight #Superbugsantibiotic resistance,experimental drugs,prions">Deadly Proteins Behind Mad Cow Disease Might Help Us Fight SuperbugsDeadly Proteins Behind Mad Cow Disease Might Help Us Fight Superbugs
                The next frontier of antibiotics might come from an unexpected place. Recent research identifies potential antibiotic candidates from inside prions—proteins capable of causing some of the deadliest brain infections ever known, such as mad cow disease.

 Scientists at the University of Pennsylvania used artificial intelligence to rapidly search hundreds of prions and prion-like proteins for peptides with antibacterial activity. They found several dozen promising candidates, two of which have already shown results treating bacterial infections in mice. The team’s findings establish “prion-related proteins as a productive source space for antibiotic discovery,” the scientists wrote in their paper, published late last week in the journal Nature Microbiology.

 Good guy prions? Prions are some of the strangest things around. They’re the misfolded form of a protein naturally found in the body. When a prion comes across its “normal” counterpart, it can somehow induce the latter to turn into a prion itself, almost like a zombie infection.

 Classic prion disorders like mad cow disease and Creutzfeldt-Jakob disease are caused by the steady accumulation of one particular type of protein, aptly named the prion protein; these disorders are universally fatal. Some scientists have also argued that other neurodegenerative conditions, such as Alzheimer’s disease, are caused by other kinds of misfolded proteins that act in a similar way to prions.   According to the study researchers, there’s growing evidence that prions and prion-like proteins are more than just harbingers of death. Studies have found that the normal prion protein and the prion-like amyloid beta (one of the drivers of Alzheimer’s) can have antimicrobial activity, for instance. So the team decided to conduct a sweeping analysis looking for antimicrobial peptide fragments within these proteins.

 The researchers had previously built an AI model intended to predict the antimicrobial activity of any given peptide fragment, named APEX 1.1. Then they let APEX scan through 19.3 million short peptide fragments found in 2,897 prion and prion-like proteins. They initially uncovered 1,179 candidates, which the team narrowed down to 75 that showed the most potential. Of these, 59 were able to inhibit the growth of at least one bacterial germ in the lab, including 42 that did so at low levels (important for dosing considerations). Finally, the researchers tested two of the strongest candidates on the skin of mice infected with Acinetobacter baumannii, a common source of drug-resistant infections in people. The candidates appeared to be roughly as effective as polymyxin B, an existing antibiotic often used as a last resort drug for certain drug-resistant infections. The researchers have coined these antibacterial fragments collected from prions as “prionins.”

 The future of prionins More research is obviously needed to verify whether the team’s prionins can actually work as hoped—and safely—in people. The researchers also note their findings don’t settle the open question as to whether prions or prion-like proteins naturally tackle bacterial infections in our body. At the same time, they do argue their work provides a strong proof of concept that prionins identified through AI can be viable antibiotic candidates for further testing. “For a long time, drug discovery has been limited not only by what we can test, but by where we choose to look,” said senior study author César de la Fuente, director of the Machine Biology Group at the University of Pennsylvania Perelman School of Medicine, in a statement from the university. “AI is changing that. It gives us a way to search the hidden layers of biology and ask whether molecules associated with one story—in this case, disease—may also carry another story with therapeutic potential.”

 With any luck, the proteins known for causing the scariest diseases around could someday turn into our antibacterial allies.      #Deadly #Proteins #Mad #Cow #Disease #Fight #Superbugsantibiotic resistance,experimental drugs,prions

The next frontier of antibiotics might come from an unexpected place. Recent research identifies potential antibiotic candidates from inside prions—proteins capable of causing some of the deadliest brain infections ever known, such as mad cow disease.

Scientists at the University of Pennsylvania used artificial intelligence to rapidly search hundreds of prions and prion-like proteins for peptides with antibacterial activity. They found several dozen promising candidates, two of which have already shown results treating bacterial infections in mice.

The team’s findings establish “prion-related proteins as a productive source space for antibiotic discovery,” the scientists wrote in their paper, published late last week in the journal Nature Microbiology.

Good guy prions?

Prions are some of the strangest things around. They’re the misfolded form of a protein naturally found in the body. When a prion comes across its “normal” counterpart, it can somehow induce the latter to turn into a prion itself, almost like a zombie infection.

Classic prion disorders like mad cow disease and Creutzfeldt-Jakob disease are caused by the steady accumulation of one particular type of protein, aptly named the prion protein; these disorders are universally fatal. Some scientists have also argued that other neurodegenerative conditions, such as Alzheimer’s disease, are caused by other kinds of misfolded proteins that act in a similar way to prions.

According to the study researchers, there’s growing evidence that prions and prion-like proteins are more than just harbingers of death. Studies have found that the normal prion protein and the prion-like amyloid beta (one of the drivers of Alzheimer’s) can have antimicrobial activity, for instance. So the team decided to conduct a sweeping analysis looking for antimicrobial peptide fragments within these proteins.

The researchers had previously built an AI model intended to predict the antimicrobial activity of any given peptide fragment, named APEX 1.1. Then they let APEX scan through 19.3 million short peptide fragments found in 2,897 prion and prion-like proteins. They initially uncovered 1,179 candidates, which the team narrowed down to 75 that showed the most potential. Of these, 59 were able to inhibit the growth of at least one bacterial germ in the lab, including 42 that did so at low levels (important for dosing considerations).

Finally, the researchers tested two of the strongest candidates on the skin of mice infected with Acinetobacter baumannii, a common source of drug-resistant infections in people. The candidates appeared to be roughly as effective as polymyxin B, an existing antibiotic often used as a last resort drug for certain drug-resistant infections.

The researchers have coined these antibacterial fragments collected from prions as “prionins.”

The future of prionins

More research is obviously needed to verify whether the team’s prionins can actually work as hoped—and safely—in people. The researchers also note their findings don’t settle the open question as to whether prions or prion-like proteins naturally tackle bacterial infections in our body.

At the same time, they do argue their work provides a strong proof of concept that prionins identified through AI can be viable antibiotic candidates for further testing.

“For a long time, drug discovery has been limited not only by what we can test, but by where we choose to look,” said senior study author César de la Fuente, director of the Machine Biology Group at the University of Pennsylvania Perelman School of Medicine, in a statement from the university. “AI is changing that. It gives us a way to search the hidden layers of biology and ask whether molecules associated with one story—in this case, disease—may also carry another story with therapeutic potential.”

With any luck, the proteins known for causing the scariest diseases around could someday turn into our antibacterial allies.

#Deadly #Proteins #Mad #Cow #Disease #Fight #Superbugsantibiotic resistance,experimental drugs,prions

Post Comment